A recent study of whole-exome and transcriptome data from more than 1000 bulk tumor tissues of 7 cancer types that were treated with ICIs reported that CXCL9 expression was one of the strongest predictors of a therapeutic response (36). The gene discussed is CXCL9; the disease is cancer.